Genetic testing in Georgia is a highly searched topic for patients planning IVF in Tbilisi and looking for clearer answers before embryo transfer or pregnancy. Genetic testing in fertility care can help identify inherited risks, support embryo selection in IVF, and reduce uncertainty for families with a known genetic history.
What Does “Genetic Testing” Mean in IVF?
In fertility treatment, “genetic testing” can refer to several different things. The most common categories are:
-
Preconception genetic testing (before pregnancy)
Tests done before trying to conceive or before IVF to evaluate inherited risks. -
Embryo genetic testing during IVF (before embryo transfer)
Testing performed on embryos created in the lab to guide embryo selection. -
Pregnancy genetic testing (after conception)
Tests done during pregnancy to evaluate fetal genetic or chromosomal conditions.
When patients search “genetic testing in Georgia,” they are often most interested in embryo genetic testing during IVF, because it can influence which embryo is selected for transfer.
Why Patients Consider Genetic Testing in Georgia
Genetic testing may be considered to:
-
reduce the risk of passing on a known inherited condition
-
help evaluate embryos for chromosome number issues
-
support decision-making after recurrent miscarriage
-
improve planning after repeated IVF failure
-
provide clearer options for families with genetic disease history
-
create a more structured embryo transfer strategy
It’s important to understand that genetic testing supports informed choices—it does not guarantee pregnancy or a live birth.
Main Types of Genetic Testing Used in IVF in Georgia (Tbilisi)
1) PGT-M (Often Called PGD): Testing for Single-Gene Disorders
PGT-M is used when there is a known risk for a specific inherited condition (single-gene disease). It is commonly searched using the older term PGD (Preimplantation Genetic Diagnosis).
When it may be recommended:
-
one or both partners are carriers of a known genetic disease
-
there is a family history of a specific inherited condition
-
a previous pregnancy was affected by the condition
-
genetic counseling indicates increased risk
What it does:
-
tests embryos for the targeted condition before transfer
-
helps identify embryos that are not affected by that condition
PGT-M typically requires careful preparation and test design, especially if the condition needs a customized approach.
2) PGT-A (Often Called PGS): Chromosome Screening
PGT-A is used to evaluate embryos for chromosome number issues (aneuploidy). Many patients still search for PGS (Preimplantation Genetic Screening) even though the modern term is PGT-A.
When it may be considered:
-
advanced maternal age
-
recurrent miscarriage where chromosomal factors are suspected
-
repeated IVF failure
-
a desire to create a more structured embryo transfer plan (case-by-case)
What it does:
-
helps identify embryos with the expected chromosome number (euploid)
-
may reduce the likelihood of transferring embryos with certain chromosome abnormalities
PGT-A is not required for every patient and should be chosen based on clinical indication.
3) PGT-SR: Testing for Chromosomal Structural Rearrangements
PGT-SR is planned when one partner has a chromosomal rearrangement (for example, a balanced translocation). Even though the carrier may be healthy, embryos can inherit unbalanced chromosome combinations.
When it may be recommended:
-
a known chromosomal rearrangement in one partner
-
recurrent miscarriages linked to chromosomal findings
-
prior genetic results suggesting structural chromosome issues
What it does:
-
helps identify embryos that are more likely to have balanced chromosome structure suitable for transfer
How Embryo Genetic Testing Works in Georgia (Step-by-Step)
Step 1) Consultation and Genetic Planning
Your fertility specialist reviews:
-
medical history and fertility diagnosis
-
genetic test results or carrier screening
-
family history and previous pregnancies
-
the most suitable testing method (PGT-M, PGT-A, PGT-SR)
For some single-gene conditions, additional planning and preparation are required before the IVF cycle begins.
Step 2) IVF or IVF/ICSI to Create Embryos
Embryos must be created through IVF. ICSI is commonly used in embryo testing cycles to support a clean and controlled lab environment for genetic analysis.
Step 3) Embryo Culture and Monitoring
Embryos develop in the lab for several days. Embryologists monitor development and identify embryos that reach the stage suitable for biopsy.
Step 4) Embryo Biopsy
A small number of cells are removed from the embryo by trained embryologists. This sample is used for genetic analysis.
Step 5) Genetic Analysis
The biopsy sample is processed using appropriate laboratory methods depending on the test type (PGT-M, PGT-A, PGT-SR). Results categorize embryos for the specific genetic goal being tested.
Step 6) Embryo Freezing and Transfer Planning (Often FET)
Because testing takes time, embryos are commonly frozen after biopsy. The transfer is then planned through a Frozen Embryo Transfer (FET) cycle once results are finalized.
Genetic Testing Before IVF: Carrier Screening and Key Benefits
Some patients consider genetic testing even before IVF starts. Preconception or pre-IVF genetic testing can include:
-
carrier screening for inherited conditions (depending on background and family history)
-
evaluation when there is a known genetic diagnosis in the family
-
guidance on whether PGT-M is needed during IVF
This step can reduce surprises later and help plan IVF more efficiently.
Genetic Testing Results: What They Mean
Results depend on the type of testing:
-
PGT-M: typically shows whether embryos are affected by, carriers of, or unaffected by the targeted condition (depending on the condition and reporting plan)
-
PGT-A: typically categorizes embryos as euploid (expected chromosome number), aneuploid (chromosome abnormality), or sometimes inconclusive/no result
-
PGT-SR: focuses on embryo chromosome balance related to the known rearrangement
Your doctor explains what results mean for embryo selection and transfer planning.
Important Limitations of Genetic Testing in IVF
Genetic testing is powerful, but it has limitations:
-
No genetic test guarantees pregnancy
Implantation depends on embryo biology, uterine readiness, timing, and overall health. -
Testing is targeted
PGT-M tests a specific condition; PGT-A screens chromosomes; neither covers every possible genetic issue. -
Mosaicism can occur
Some embryos have a mix of normal and abnormal cells. Biopsy samples only a small number of cells, so results can be complex in certain cases. -
Inconclusive results can happen
Sometimes the sample is insufficient or does not provide a clear outcome. -
Prenatal care is still important
IVF genetic testing does not replace pregnancy care and monitoring once pregnancy is achieved.
Who Benefits Most From Genetic Testing in Georgia?
Genetic testing is more commonly considered when:
-
there is a known inherited disease risk
-
one partner carries a structural chromosome issue
-
there are recurrent miscarriages
-
previous IVF cycles failed
-
maternal age is higher and embryo aneuploidy risk is increased
-
the couple wants a structured embryo transfer strategy and has enough embryos for meaningful testing
A fertility specialist should recommend genetic testing based on your personal medical and genetic profile.
Timeline for International Patients Seeking Genetic Testing in Tbilisi, Georgia
International patients often prefer a clear travel plan. Many genetic testing pathways are structured as:
-
Pre-arrival planning: online consultation, file review, genetic strategy selection
-
IVF phase in Georgia: stimulation monitoring, egg retrieval, embryo creation, embryo biopsy
-
Testing period: lab analysis and results reporting
-
Transfer phase (often FET): return visit or scheduled transfer plan once results are ready
Because embryo testing often uses frozen transfer planning, patients frequently schedule either two shorter trips or one longer stay depending on timing and clinical coordination.
Frequently Asked Questions
Is genetic testing the same as gender selection?
No. Genetic testing in IVF is primarily designed to address medical genetic risks and chromosome issues. Any embryo selection decisions should remain ethical and medically appropriate.
Can genetic testing reduce miscarriage risk?
In some cases, selecting embryos without certain chromosome abnormalities may reduce miscarriage risk related to aneuploidy. However, miscarriages can also have non-genetic causes.
Should everyone do genetic testing with IVF?
Not necessarily. The value depends on diagnosis, age, embryo numbers, and personal medical history. A specialist should guide the decision.
Final Note: Genetic Testing Should Be Personalized
The best outcomes come from:
-
clear indication for testing
-
correct test selection (PGT-M/PGD, PGT-A/PGS, PGT-SR)
-
strong lab standards and biopsy technique
-
a well-planned transfer strategy (often FET)
-
transparent counseling about what testing can and cannot guarantee
If you are considering genetic testing in Georgia (Tbilisi), a consultation and medical review can help you choose the right approach and create an organized, patient-friendly timeline.